Alexandria For Pharmaceuticals & Chemical Industries Balance Sheet Health
Financial Health criteria checks 6/6
Alexandria For Pharmaceuticals & Chemical Industries has a total shareholder equity of EGP771.1M and total debt of EGP3.5M, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are EGP1.3B and EGP522.5M respectively. Alexandria For Pharmaceuticals & Chemical Industries's EBIT is EGP254.0M making its interest coverage ratio -25.1. It has cash and short-term investments of EGP141.0M.
Key information
0.5%
Debt to equity ratio
ج.م3.52m
Debt
Interest coverage ratio | -25.1x |
Cash | ج.م141.04m |
Equity | ج.م771.09m |
Total liabilities | ج.م522.50m |
Total assets | ج.م1.29b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AXPH's short term assets (EGP922.3M) exceed its short term liabilities (EGP508.1M).
Long Term Liabilities: AXPH's short term assets (EGP922.3M) exceed its long term liabilities (EGP14.4M).
Debt to Equity History and Analysis
Debt Level: AXPH has more cash than its total debt.
Reducing Debt: AXPH's debt to equity ratio has reduced from 0.6% to 0.5% over the past 5 years.
Debt Coverage: AXPH's debt is well covered by operating cash flow (4607.1%).
Interest Coverage: AXPH earns more interest than it pays, so coverage of interest payments is not a concern.